214 related articles for article (PubMed ID: 26009537)
1. Itch and liver: management in primary care.
Hegade VS; Kendrick SF; Rehman J; Jones DE
Br J Gen Pract; 2015 Jun; 65(635):e418-20. PubMed ID: 26009537
[No Abstract] [Full Text] [Related]
2. [Pruritus in liver disease. Pathogenesis and treatment].
Kremer AE; Maillette de Buy Wenniger L; Oude Elferink RP; Beuers U
Ned Tijdschr Geneeskd; 2011; 155(52):A4045. PubMed ID: 22217242
[TBL] [Abstract][Full Text] [Related]
3. [Management of pruritus in patients with cholestatic liver disease].
Kremer AE; Kraus MR
MMW Fortschr Med; 2016 Jun; 158(12):64-7. PubMed ID: 27324009
[No Abstract] [Full Text] [Related]
4. The efficacy and safety of bile Acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus.
Tandon P; Rowe BH; Vandermeer B; Bain VG
Am J Gastroenterol; 2007 Jul; 102(7):1528-36. PubMed ID: 17403073
[TBL] [Abstract][Full Text] [Related]
5. Obstetric hepatosis: treatment with cholestyramine and interim response to steroids.
Lutz EE; Margolis AJ
Obstet Gynecol; 1969 Jan; 33(1):64-71. PubMed ID: 5773873
[No Abstract] [Full Text] [Related]
6. Cholestyramine therapy in patients with a paucity of intrahepatic bile ducts.
Sharp HL; Carey JB; White JG; Krivit W
J Pediatr; 1967 Nov; 71(5):723-36. PubMed ID: 6054760
[No Abstract] [Full Text] [Related]
7. [Benign recurrent cholestasis].
Erlinger S; Beaudoin M; Benhamou JP
Ann Med Interne (Paris); 1972 Oct; 123(10):875-6. PubMed ID: 4659248
[No Abstract] [Full Text] [Related]
8. Benign familial recurrent intrahepatic cholestasis.
Lesser PB
Am J Dig Dis; 1973 Apr; 18(4):259-64. PubMed ID: 4695611
[No Abstract] [Full Text] [Related]
9. [Treatment of cholestasis with cholestyramine].
Tashev T; Brailski Kh; Braikova N; Mendizova A; Adzharov D
Vutr Boles; 1974; 13(1):60-5. PubMed ID: 4428739
[No Abstract] [Full Text] [Related]
10. Mechanisms of pruritus in cholestasis: understanding and treating the itch.
Beuers U; Wolters F; Oude Elferink RPJ
Nat Rev Gastroenterol Hepatol; 2023 Jan; 20(1):26-36. PubMed ID: 36307649
[TBL] [Abstract][Full Text] [Related]
11. Pruritus of unknown origin and elevated total serum bile acid levels in patients without clinically apparent liver disease.
Eisendle K; Müller H; Ortner E; Talasz H; Graziadei I; Vogel W; Höpfl R
J Gastroenterol Hepatol; 2011 Apr; 26(4):716-21. PubMed ID: 21155876
[TBL] [Abstract][Full Text] [Related]
12. Benign recurrent cholestasis.
Beaudoin M; Feldmann G; Erlinger S; Benhamou JP
Digestion; 1973; 9(1):49-65. PubMed ID: 4777519
[No Abstract] [Full Text] [Related]
13. Advances in pathogenesis and treatment of pruritus.
Bolier R; Oude Elferink RP; Beuers U
Clin Liver Dis; 2013 May; 17(2):319-29. PubMed ID: 23540505
[TBL] [Abstract][Full Text] [Related]
14. Itch Management: Systemic Agents.
Pongcharoen P; Fleischer AB
Curr Probl Dermatol; 2016; 50():46-53. PubMed ID: 27578071
[TBL] [Abstract][Full Text] [Related]
15. Pruritus associated with cholestasis. A review of pathogenesis and management.
Khandelwal M; Malet PF
Dig Dis Sci; 1994 Jan; 39(1):1-8. PubMed ID: 8281842
[No Abstract] [Full Text] [Related]
16. The itch of liver disease.
Bergasa NV
Semin Cutan Med Surg; 2011 Jun; 30(2):93-8. PubMed ID: 21767769
[TBL] [Abstract][Full Text] [Related]
17. The challenge of cholestatic pruritus.
Bolier AR; Peri S; Oude Elferink RP; Beuers U
Acta Gastroenterol Belg; 2012 Dec; 75(4):399-404. PubMed ID: 23402082
[TBL] [Abstract][Full Text] [Related]
18. [Dynamics of various parameters of cholestasis during intermittent therapy with cholestyramine].
Mikulecký M
Vnitr Lek; 1976 Dec; 22(12):1192-9. PubMed ID: 1007053
[No Abstract] [Full Text] [Related]
19. [Intrahepatic cholestasis during pregnancy].
Krejs GJ; Blum AL
Minerva Med; 1974 Dec; 65(91):4830-5. PubMed ID: 4449612
[No Abstract] [Full Text] [Related]
20. [Cholestyramine therapy in intrahepatic cholestasis].
van Berge Henegouwen GP; Brandt KH
Ned Tijdschr Geneeskd; 1974 Jul; 118(28):1074-9. PubMed ID: 4848265
[No Abstract] [Full Text] [Related]
[Next] [New Search]
